Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study
出版年份 2012 全文链接
标题
Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study
作者
关键词
-
出版物
BMC Nephrology
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2012-11-20
DOI
10.1186/1471-2369-13-150
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
- (2013) Regina Kunz et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and Safety of Paricalcitol Therapy for Chronic Kidney Disease: A Meta-Analysis
- (2012) J. Cheng et al. Clinical Journal of the American Society of Nephrology
- Antiproteinuric Response to Add-on Aliskiren in Proteinuric Patients Treated With Dual Blockade of the Renin-Angiotensin System: A 12-Month Prospective Uncontrolled Study
- (2011) Luca De Nicola et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Oral Calcitriol for Reduction of Proteinuria in Patients With IgA Nephropathy: A Randomized Controlled Trial
- (2011) Li-Jun Liu et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy
- (2011) L. De Nicola et al. Clinical Journal of the American Society of Nephrology
- Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin–angiotensin–aldosterone system inhibition
- (2011) Min Jeong Kim et al. KIDNEY INTERNATIONAL
- Intensive Versus Conventional Therapy to Slow the Progression of Idiopathic Glomerular Diseases
- (2010) Stefano Bianchi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Are vitamin D receptor agonists like angiotensin-converting enzyme inhibitors without side effects?
- (2010) Rajiv Agarwal KIDNEY INTERNATIONAL
- Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes
- (2010) Dilip K. Deb et al. KIDNEY INTERNATIONAL
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
- (2010) Dick de Zeeuw et al. LANCET
- Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial
- (2009) Steven Fishbane et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
- (2009) Andrew S. Levey et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Renoprotective effects of vitamin D analogs
- (2009) Yan Chun Li KIDNEY INTERNATIONAL
- Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease
- (2008) Pooneh Alborzi et al. HYPERTENSION
- Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor-Mediated Sequestration of NF- B Signaling
- (2008) X. Tan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Role of Remission Clinics in the Longitudinal Treatment of CKD
- (2008) P. Ruggenenti et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase
- (2008) Z. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The importance of the intrarenal renin–angiotensin system
- (2008) Juan Carlos Q Velez Nature clinical practice. Nephrology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now